Edgewise Therapeutics, Inc. EWTX Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s accrued liabilities, current?
- Edgewise Therapeutics, Inc. (EWTX) reported accrued liabilities, current of $8.56M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Edgewise Therapeutics, Inc.'s accrued liabilities, current increased by 16.4% year-over-year, from $7.35M to $8.56M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s accrued liabilities, current has grown at a 37.9% compound annual growth rate (CAGR), from $1.59M to $7.92M.